Trial intelligence / Profile preview

Phase IIb FLU-v Broad Spectrum Influenza Vaccine in H1N1 Human Challenge

2016-002134-74Phase 2Completed

Sponsor
SEEK
Start
Jun 2016
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in influenza comparing FLU-v vaccine with Placebo (2 arms). Primary endpoint: Incidence of Mild to Moderate Influenza Disease (MMID). Started Jun 2016; status: completed.

02

Drugs

influenza vaccine (surface antigen, inactivated, adjuvanted)
03

Conditions

influenza

Beyond the preview

Go deeper on 2016-002134-74.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-002134-74.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call